Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Consolidated Statements of Cash Flows (Unaudited)

v3.22.1
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
OPERATING ACTIVITIES    
Net loss and comprehensive loss $ (9,221) $ (14,794)
Items not involving current cash flows:    
Depreciation and amortization 156 97
Interest expense on lease liabilities 18 14
Share-based compensation expense 593 769
(Gain) loss on change in fair value of warrants (2,909) 3,010
Accrued interest on Note payable 37
Warrant liability-foreign exchange adjustment 44
Changes in non-cash working capital balances    
Receivables 8,280
Prepaid expenses and deposits 1,233 (981)
Accounts payable and accrued liabilities (75) (1,506)
Cash used in operating activities (1,925) (13,310)
FINANCING ACTIVITIES    
Exercise of Derivative warrants 8,000
January 2021 Equity Offering, net of issuance costs 10,231
February 2021 Equity Offering, net of issuance costs 21,093
Exercise of Equity warrants 1,985
Exercise of stock options 14
Note payable 122
Repayment of lease obligations (101) (44)
Cash (used in) provided by financing activities (101) 41,401
INVESTING ACTIVITIES    
Purchase of property, plant and equipment (106) (93)
Purchase of patents (62) (97)
Cash used in investing activities (168) (190)
(Decrease) increase in cash during the period (2,194) 27,901
Cash and cash equivalents, beginning of the period 32,306 25,469
Cash and cash equivalents, end of the period $ 30,112 $ 53,370